Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma
about
Prognostic factors in elderly patients with breast cancerAn update on a systematic review of the use of geriatric assessment for older adults in oncology.Treatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futile.Primary skeletal muscle diffuse large B cell lymphoma: A case report and review of the literature.International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancerComparison of Three Chemotherapy Regimens in Elderly Patients with Diffuse Large B Cell Lymphoma: Experience at a Single National Reference Center in Mexico.Diffuse large B-cell lymphoma in adults aged 75 years and older: a single institution analysis of cause-specific survival and prognostic factors.Impact of comorbidities on the treatment of non-Hodgkin's lymphoma: a systematic review.Motivation and mortality in older women with early stage breast cancer: A longitudinal study with ten years of follow-up.Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with diffuse large B-cell lymphoma: an Australian retrospective analysis.R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma.Analysis of elderly patients with diffuse large B-cell lymphoma: aggressive therapy is a reasonable approach for 'unfit' patients classified by comprehensive geriatric assessment.Prognostic significance of geriatric assessment in combination with laboratory parameters in elderly patients with aggressive non-Hodgkin lymphoma.Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphoma.Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with "standard" immunochemotherapy: A large retrospective study from 4 institutions.Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma.Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B-Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment.Comparison of outcomes among patients aged 80 and over and younger patients with diffuse large B-cell lymphoma: a population based study.Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Rituximab plus Bendamustine as front line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin's lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi.Guidelines for the management of diffuse large B-cell lymphoma.
P2860
Q26852883-060BE9DB-F0E3-4571-B3EA-E3E8CA65A90FQ35047679-48D74088-4778-4C83-BD85-D85A270F9F01Q35247997-8226FE8E-04C6-4817-AAE8-8114F9530F8DQ36085413-2F0D0C71-68D7-4F08-86C4-AA659F1036A9Q36925135-9A685152-9188-4AAD-9854-7BDB9CBB4DF1Q37120684-C7091410-C939-460E-9106-C0DC1D38324AQ37371839-E6E65DD9-3518-4DBE-8983-11E0E8816AF1Q38378318-7D657C2D-FD3B-4E1B-BC07-0AAA189F18BFQ39093776-5E8077AB-7022-49A4-B0B4-2BF7C5EA991EQ40576636-3900827E-992F-4B23-874C-A69238F9ADC7Q40590566-C34A5318-183D-4946-A203-71FE32C8D304Q41661509-CE94D0A0-1D90-49ED-86F2-B2A65657946AQ43529478-0CF670DC-D9A3-4123-A299-779FD25313FEQ47565688-44544FC1-47E6-422C-B474-768AB7D5775FQ48229580-78090816-1317-4A97-B310-7F6CE5DAEF68Q48266876-082B5855-1B9F-4F1A-9CAF-D8C1E98B940DQ48944967-8F640690-171C-435D-949C-D45352ECF6BBQ50112942-B51E72FA-F434-49A1-958A-FDF19B2F027DQ50856541-2A6E55CC-F652-4E2E-BE93-16162AA497AEQ52836250-F18A64F1-8A99-4A3B-B7F8-BDDEE957756FQ54214982-DDCC3A7C-EDF6-4FE7-818B-35EF38DCFEAAQ54708579-0C9A1087-E115-44E9-889A-C04F9903AC07
P2860
Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Modulated chemotherapy accordi ...... diffuse large B-cell lymphoma
@ast
Modulated chemotherapy accordi ...... diffuse large B-cell lymphoma
@en
type
label
Modulated chemotherapy accordi ...... diffuse large B-cell lymphoma
@ast
Modulated chemotherapy accordi ...... diffuse large B-cell lymphoma
@en
prefLabel
Modulated chemotherapy accordi ...... diffuse large B-cell lymphoma
@ast
Modulated chemotherapy accordi ...... diffuse large B-cell lymphoma
@en
P2093
P2860
P1433
P1476
Modulated chemotherapy accordi ...... diffuse large B-cell lymphoma
@en
P2093
Andrés José Marìa Ferreri
Annalisa Giacalone
Arben Lleshi
Armando Santoro
Elena Ravaioli
Lilj Uziel
Lucia Fratino
Massimiliano Berretta
Massimo Magagnoli
Monica Balzarotti
P2860
P304
P356
10.1634/THEONCOLOGIST.2011-0417
P577
2012-05-18T00:00:00Z